Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Integra Lifesciences Holdings Corp receives FDA clearance for integra Titanium bone wedges


Thursday, 27 Feb 2014 08:30am EST 

Integra Lifesciences Holdings Corp:Announces Introduction of the Integra Titanium Bone Wedges, designed for internal fixation for bone fractures or osteotomies in the foot and ankle.System has received 510 clearance from the U.S. Food and Drug Administration (FDA), and will be featured at the American College of Foot and Ankle Surgeons (ACFAS) 72(nd)Annual Scientific Conference, Feb. 27 - March 2, 2014, in Orlando, Florida.Integra Titanium Bone Wedges may be used in corrective procedures, such as Cotton (opening wedge) osteotomies of the medial cuneiform and Evans lengthening osteotomies. 

Company Quote

50.26
1.28 +2.61%
17 Sep 2014